Victor Lobanenkov
Overview
Explore the profile of Victor Lobanenkov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
2046
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Loukinov D, Anderson A, Mkrtichyan M, Ghochikyan A, Rivero-Hinojosa S, Tucker J, et al.
Int J Mol Sci
. 2023 Mar;
24(6).
PMID: 36983050
Cancer testis antigens are ideal for tumor immunotherapy due to their testis-restricted expression. We previously showed that an immunotherapeutic vaccine targeting the germ cell-specific transcription factor BORIS (CTCFL) was highly...
2.
Boukaba A, Liu J, Ward C, Wu Q, Arnaoutov A, Liang J, et al.
Proc Natl Acad Sci U S A
. 2022 Sep;
119(40):e2204071119.
PMID: 36179046
Many tumors express meiotic genes that could potentially drive somatic chromosome instability. While germline cohesin subunits SMC1B, STAG3, and REC8 are widely expressed in many cancers, messenger RNA and protein...
3.
Teplyakov E, Wu Q, Liu J, Pugacheva E, Loukinov D, Boukaba A, et al.
Oncotarget
. 2017 Nov;
8(43):73448-73468.
PMID: 29088719
The gene, is a testis-specific paralog frequently erroneously activated in cancer, although its exact role in cancer remains unclear. BORIS is both a transcription factor and an architectural chromatin protein....
4.
Pugacheva E, Teplyakov E, Wu Q, Li J, Chen C, Meng C, et al.
Epigenetics Chromatin
. 2016 Sep;
9(1):35.
PMID: 27588042
Background: A common aberration in cancer is the activation of germline-specific proteins. The DNA-binding proteins among them could generate novel chromatin states, not found in normal cells. The germline-specific transcription...
5.
Schwarzenbach H, Eichelser C, Steinbach B, Tadewaldt J, Pantel K, Lobanenkov V, et al.
BMC Cancer
. 2014 Nov;
14:796.
PMID: 25363021
Background: As cancer-testis MAGE-A antigens are targets for tumor immunotherapy, it is important to study the regulation of their expression in cancers. This regulation appears to be rather complex and...
6.
Mendez-Catala C, Gretton S, Vostrov A, Pugacheva E, Farrar D, Ito Y, et al.
Neoplasia
. 2013 Aug;
15(8):898-912.
PMID: 23908591
We previously reported the association of elevated levels of the multifunctional transcription factor, CCCTC binding factor (CTCF), in breast cancer cells with the specific anti-apoptotic function of CTCF. To understand...
7.
Nakahashi H, Kieffer Kwon K, Resch W, Vian L, Dose M, Stavreva D, et al.
Cell Rep
. 2013 May;
3(5):1678-1689.
PMID: 23707059
The "CTCF code" hypothesis posits that CTCF pleiotropic functions are driven by recognition of diverse sequences through combinatorial use of its 11 zinc fingers (ZFs). This model, however, is supported...
8.
Lobanenkov V, Loukinov D, Pugacheva E
Epigenomics
. 2011 Nov;
3(3):261-6.
PMID: 22122336
The main objective of this conference was to provide solid evidence that environmental exposures during early development can affect faithful reproduction of individual parental epigenomes without changing DNA sequence in...
9.
Kosaka-Suzuki N, Suzuki T, Pugacheva E, Vostrov A, Morse 3rd H, Loukinov D, et al.
J Biol Chem
. 2011 Jun;
286(31):27378-88.
PMID: 21659515
Cancer-testis antigens (CTAs) are normally expressed in testis but are aberrantly expressed in a variety of cancers with varying frequency. More than 100 proteins have been identified as CTA including...
10.
Mkrtichyan M, Ghochikyan A, Davtyan H, Movsesyan N, Loukinov D, Lobanenkov V, et al.
Cell Immunol
. 2011 Jun;
270(2):188-97.
PMID: 21641588
Here, we analyze for the first time the immunological and therapeutic efficacy of a dendritic cell (DC) vaccine based on a cancer-testis antigen, Brother of regulator of imprinted sites (BORIS),...